Bioresorbable Silicon Electronic Sensor May Monitor Brain

This article originally appeared here.
Share this content:
Bioresorbable Silicon Electronic Sensor May Monitor Brain
Bioresorbable Silicon Electronic Sensor May Monitor Brain

MONDAY, Jan. 18, 2016 (HealthDay News) -- An novel implant utilizing a dissolvable sensor may be able to transmit information wirelessly to physicians during surgery or after a brain injury, according to an experimental study published online Jan. 18 in Nature.

Rory Murphy, M.D., chief neurosurgery resident at the Washington University School of Medicine in St. Louis, and colleagues tested a sensor the size of a pencil tip that's connected to a penny-sized transmitter.

The authors reported that in their study conducted in rats, the new device worked about as well as existing devices at measuring pressure and temperature. According to Murphy, the device wouldn't necessarily need to be bigger in humans. The material dissolves over time.

Researchers are looking for funding from the U.S. Department of Defense, which studies brain injury, to launch the next stages of laboratory testing, Murphy told HealthDay. That phase of research could take three to four years before tests in humans could begin, he said.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

Congress Approves Bill Expanding Private Care for VA Patients

Congress Approves Bill Expanding Private Care for VA ...

New bill would open up access to private doctors for veterans

AAP Recommending Injectable Flu Shot for 2018-19 Flu Season

AAP Recommending Injectable Flu Shot for 2018-19 Flu ...

Children should receive injectable vaccine, which has been shown to be more consistently effective

Neurologists Identify New Type of Vertigo

Neurologists Identify New Type of Vertigo

Long-term prognosis favorable, with improvement of symptoms in more than half of patients